FR2685638A1 - Compositions for cosmetic and/or dermatological use, comprising a combination of pyrithione zinc, piroctone olamine and a derivative of collagen and of fatty acid - Google Patents
Compositions for cosmetic and/or dermatological use, comprising a combination of pyrithione zinc, piroctone olamine and a derivative of collagen and of fatty acid Download PDFInfo
- Publication number
- FR2685638A1 FR2685638A1 FR9116406A FR9116406A FR2685638A1 FR 2685638 A1 FR2685638 A1 FR 2685638A1 FR 9116406 A FR9116406 A FR 9116406A FR 9116406 A FR9116406 A FR 9116406A FR 2685638 A1 FR2685638 A1 FR 2685638A1
- Authority
- FR
- France
- Prior art keywords
- sep
- weight
- composition according
- fatty acid
- collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/068—Microemulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
La présente invention est relative à des compositions pour l'usage cosmétique et/ou dermatologique, plus particulièrement destinées à l'hygiène et au soin des peaux acnéiques, lesquelles compositions contiennent en tant que principe actif, une association de piroctone olamine et de pyrithione zinc. Les peaux acnéiques résultent d'une association de plusieurs composantes. Au départ existe une hypersécrétion sébacée, accompagnée d'une dyskératinisation qui induit, au niveau des glandes sébacées, une rétention de sébum, provoquant la formation de comédons. La glande sébacée engorgée est un lieu propice à la prolifération de microorganismes : le
Propionibacterium acnes, le staphylocoque, et le Pytirosporum ovale.A ceci viennent s'ajouter une irritation puis une inflammation déclenchées par de nombreux facteurs, notamment par la présence d'acides gras libres qui subissent des oxydations et peroxydations, entraînant la formation de radicaux libres, générateurs de phénomènes inflammatoires. L'ensemble de ces phénomènes entraîne la formation des pustules caractéristiques de l'acné. The present invention relates to compositions for cosmetic and / or dermatological use, more particularly intended for the hygiene and care of acne skin, which compositions contain, as active ingredient, a combination of piroctone olamine and pyrithione zinc . Acne skin results from a combination of several components. Initially exists a sebaceous hypersecretion, accompanied by a dyskeratinization which induces, at the level of the sebaceous glands, a retention of sebum, causing the formation of comedones. The congested sebaceous gland is a place conducive to the proliferation of microorganisms: the
Propionibacterium acnes, staphylococcus, and Pytirosporum ovale. In addition, irritation and inflammation are triggered by many factors, including the presence of free fatty acids that undergo oxidation and peroxidation, resulting in the formation of free radicals. , generators of inflammatory phenomena. All of these phenomena lead to the formation of the pustules characteristic of acne.
Les traitements antiacnéiques classiques associent généralement l'utilisation, d'une part, d'antibiotiques et d'antiseptiques, agissant sur la composante infectieuse, et d'autre part, de kératolytiques, agissant sur la rétention de sébum. Conventional anti-acne treatments generally combine the use, on the one hand, of antibiotics and antiseptics, acting on the infectious component, and on the other hand, keratolytics, acting on the retention of sebum.
En ce qui concerne la composante infectieuse, les traitements antibiotiques et antiseptiques préconisés ont essentiellement pour but la diminution de la flore bactérienne, généralement considérée comme responsable de la surinfection des glandes sébacées. Toutefois, la diminution de la flore bactérienne ainsi provoquée entraîne la prolifération de Pityrosporum ovale. Or, il semble que l'infection par Pityrosporum ovale joue également un rôle important dans la pathogenèse de l'acné, et en particulier dans le déclenchement du processus inflammatoire ce microorganisme est en effet en grande partie responsable des oxydations et peroxydations des acides gras accumulés dans les glandes sébacées. Regarding the infectious component, the recommended antibiotic and antiseptic treatments are mainly aimed at reducing the bacterial flora, generally considered to be responsible for superinfection of the sebaceous glands. However, the decrease in the bacterial flora thus caused leads to the proliferation of Pityrosporum ovale. However, it seems that Pityrosporum ovale infection also plays an important role in the pathogenesis of acne, and in particular in triggering the inflammatory process this microorganism is indeed largely responsible for oxidation and peroxidation of accumulated fatty acids. in the sebaceous glands.
En ce qui concerne la rétention de sébum, les ératolytiques permettent la dissolution du bouchon sébacé ; ils provoquent toutefois un amincissement de la couche cornée, ce qui entraîne une déshydratation et un dessèchement de la peau, et une augmentation de sa sensibilité aux agressions d'origines diverses. Cet état est en outre accentué par l'effet irritant de certains des traitements antiseptiques locaux associés, et parfois par des produits d'hygiène trop agressifs, qui, sous prétexte d'éliminer l'excès de sébum, conduisent à la délipidation de l'épiderme. As regards the retention of sebum, the erratolytics allow the dissolution of the sebaceous plug; however, they cause a thinning of the stratum corneum, resulting in dehydration and drying of the skin, and an increase in its sensitivity to aggression of various origins. This state is further accentuated by the irritating effect of some of the associated local antiseptic treatments, and sometimes by too aggressive hygiene products, which, under the pretext of eliminating the excess of sebum, lead to the delipidation of the epidermis.
La présente Invention a pour but de pourvoir à an produit de soin et de traitement des peaux acnéiques, actif au niveau de différents facteurs responsables de la composante inflammatoire de l'acné. The present invention aims to provide an acne skin care and treatment product, active in various factors responsible for the inflammatory component of acne.
L'inventeur a constaté que des compositions comprenant une association de pyrithione zinc, de piroctone olamine, en combinaison avec un agent tensioactif amionique, dérivé de collagène et d'acide gras, étaient particulièrement actives pour prévenir la prolifération de Pityrosporum ovale. The inventor has found that compositions comprising a combination of pyrithione zinc, piroctone olamine, in combination with an amionic surfactant, derived from collagen and fatty acid, were particularly active in preventing the proliferation of Pityrosporum ovale.
La présente invention a pour objet une composition pour l'usage cosmétique et/ou dermatologique, caractérisée en ce qu'elle comprend, en tant que principe actif, une association de piroctone olamine et de pyrithione zinc, et d'un tensio-actif amionique dérivé de collagène et d'acide gras.. The present invention relates to a composition for cosmetic and / or dermatological use, characterized in that it comprises, as active ingredient, a combination of piroctone olamine and pyrithione zinc, and an amionic surfactant. derivative of collagen and fatty acid ..
Selon un mode de réalisation préféré d'une composition conforme à l'invention, ladite composition comprend en outre au moins un agent antioxydant. According to a preferred embodiment of a composition according to the invention, said composition further comprises at least one antioxidant agent.
En effet, l'adjonction d'au moins un agent antioxydant à une composition conforme à l'invention, augmente l'activité anti-irritante et anti-inflammatoire de ladite composition. Indeed, the addition of at least one antioxidant agent to a composition according to the invention increases the anti-irritant and anti-inflammatory activity of said composition.
De manière générale, tous les agents antioxydants piégeant les radicaux libres, permettant d'éviter l'oxydation et la peroxydation des acides gras et compatibles avec une formulation destinée à l'usage dermatologique et/ou cosmétique peuvent être employés. Il est possible de citer, par exemple, et de façon non limitative, la vitamine E et ses dérivés, la vitamine A, la vitamine C, et leurs dérivés, la superoxyde dismutase, l'allopurinol, la cystéine, les flavophérols, les dérivés quinoniques, l'extrait de Gingko biloba, le butylhydroxytoluène, le sélénium, etc... In general, all the antioxidant agents trapping free radicals, making it possible to prevent oxidation and peroxidation of fatty acids and compatible with a formulation intended for dermatological and / or cosmetic use may be employed. It is possible to cite, for example, and without limitation, vitamin E and its derivatives, vitamin A, vitamin C, and their derivatives, superoxide dismutase, allopurinol, cysteine, flavopherols, derivatives quinone, Gingko biloba extract, butylhydroxytoluene, selenium, etc.
De manière avantageuse, l'agent anti-oxydant est la vitamine E, sous forme de micro-émulsion. Advantageously, the antioxidant agent is vitamin E, in the form of a microemulsion.
Selon un mode de réalisation préféré d'une composition conforme à l'invention, elle comprend entre 0,05 et 2%, en poids, de piroctone olamine, entre 0,1 et 3%, en poids, de pyrithione zinc, et entre 5 et 20 %, en poids, de dérivé de collagène et d'acide gras. According to a preferred embodiment of a composition according to the invention, it comprises between 0.05 and 2%, by weight, of piroctone olamine, between 0.1 and 3%, by weight, of pyrithione zinc, and between 5 and 20%, by weight, of collagen derivative and fatty acid.
De façon avantageuse, elle comprend en outre de 0,5 à 10%, en poids, de vitamine E. Advantageously, it also comprises from 0.5 to 10%, by weight, of vitamin E.
La piroctone olamine et la pyrithione zinc peuvent également être associées à d'autres agents antifongiques, antiseptiques et/ou antiséborrhéiques, par exemple des dérivés imidazolés, des dérivés iodés, des dérivés de sélénium, des sels d'undécylénate, des esters d'acide parahydroxybenzoïque, des ammoniums quaternaires, des alcools, l'acide lactique, l'acide borique, la chlorhexidine, l'héxétidine, le soufre, les acides aminés soufrés, les goudrons, des extraits végétaux tels que les extraits d'ortie, de bouleau, d'hamamélis, ainsi que des vitamines A, H, B6. Piroctone olamine and zinc pyrithione can also be combined with other antifungal, antiseptic and / or antiseborrhoeic agents, for example imidazole derivatives, iodinated derivatives, selenium derivatives, undecylenate salts, acid esters and the like. parahydroxybenzoic acid, quaternary ammoniums, alcohols, lactic acid, boric acid, chlorhexidine, hexetidine, sulfur, sulfur amino acids, tars, plant extracts such as nettle extract, birch extract , witch hazel, as well as vitamins A, H, B6.
Les compositions conformes à l'invention permettent la préparation d'un grand nombre de produits destinés à l'usage cosmétique et/ou dermatologique, tels que des crèmes, pommades, lotions, poudres, savons, etc... Lorsque l'association piroctone olamine/pyrithione zinc est utilisée dans des préparations destinées à demeurer sur la peau, telles que des crèmes, on choisira de préférence dans les gammes mentionnées plus haut, les plus faibles concentrations en principes actifs lorsqu'il s'agit de préparation destinées à être rincées, telles que des savons, on choisira des concentrations plus importantes. The compositions according to the invention allow the preparation of a large number of products intended for cosmetic and / or dermatological use, such as creams, ointments, lotions, powders, soaps, etc. When the piroctone association olamine / pyrithione zinc is used in preparations intended to remain on the skin, such as creams, it will preferably be chosen from the ranges mentioned above, the lowest concentrations of active ingredients when it comes to preparation to be rinsed, such as soaps, larger concentrations will be chosen.
De manière avantageuse, les compositions conformes à l'invention sont utilisées pour l'obtention d'un savon dont la composition comprend en outre une base lavante, au moins un agent humectant et/ou hydratant, au moins un agent surgraissant, et, optionnellement, d'autres principes actifs antifongiques, antiseptiques et/ou antiséborrhéiques, des parfums, colorants, agents de texture, et conservateurs appropriés. Advantageously, the compositions in accordance with the invention are used for obtaining a soap whose composition also comprises a washing base, at least one humectant and / or moisturizing agent, at least one superfatting agent, and, optionally , other antifungal, antiseptic and / or antiseborrheic active ingredients, suitable fragrances, colorants, texturizing agents and preservatives.
Les bases lavantes pouvant être utilisées sont constituées d'un ou plusieurs tensio-actifs anioniques, ou d'un ou plusieurs tensio-actifs cationiques, et/ou d'un ou plusieurs tensio-actifs amphotères, la pyrithione zinc formant des complexes avec les tensio-actifs non ioniques ; de préférence seront utilisés des tensioactifs doux, afin d'éviter une délipidation trop importante de l'épiderme. The washing bases that can be used consist of one or more anionic surfactants, or one or more cationic surfactants, and / or one or more amphoteric surfactants, the zinc pyrithione forming complexes with the nonionic surfactants; preferably mild surfactants will be used, in order to avoid too much delipidation of the epidermis.
Parmi les agents humectants et/ou hydratants utilisables dans le cadre de la présente invention, on peut citer : le pidolate de sodium, l'urée, le sorbitol, le glycérol, le N.M.F., les glycosaminoglycannes, le lactate de sodium, les protéines du lait, les sels de guanidine, le collagène, le propylène glycol. Among the humectants and / or moisturizers that can be used in the context of the present invention, mention may be made of: sodium pidolate, urea, sorbitol, glycerol, NMF, glycosaminoglycans, sodium lactate, proteins of the milk, guanidine salts, collagen, propylene glycol.
Comme agents surgraissants, on peut utiliser par exemple des dérivés d'huiles végétales, animales, ou minérales, ainsi que des huiles de synthèse ; la partie hydrophobe de certains tensio-actifs joue également le rôle d'agent surgraissant. As superfatting agents, it is possible to use, for example, vegetable, animal or mineral oil derivatives, as well as synthetic oils; the hydrophobic part of certain surfactants also acts as a superfatting agent.
De façon avantageuse, le pH du savon obtenu est compris entre 4 et 7. Il est possible d'utiliser, dans ce but, de l'acide borique, de l'acide sorbique, ou de l'acide citrique. Advantageously, the pH of the soap obtained is between 4 and 7. It is possible to use, for this purpose, boric acid, sorbic acid, or citric acid.
Un savon liquide conforme à la présente invention comprend, avantageusement, entre 0,5 et 2% en poids de pyrithione zinc, entre 0,3 et 1% en poids de piroctone olamine, entre 5 et 20 %, en poids, de dérivé de collagène et d'acide gras, entre 0,5 et 20 % en poids de vitamine E, entre 1 et 10% en poids d'agents surgraissants, entre 1 et 10% en poids d'agents hydratants, entre 10 et 40% en poids de tensio-actifs anioniques et/ou de tensio-actifs amphotères doux. A liquid soap according to the present invention comprises, advantageously, between 0.5 and 2% by weight of pyrithione zinc, between 0.3 and 1% by weight of piroctone olamine, between 5 and 20%, by weight, of collagen and fatty acid, between 0.5 and 20% by weight of vitamin E, between 1 and 10% by weight of superfatting agents, between 1 and 10% by weight of moisturizing agents, between 10 and 40% by weight, weight of anionic surfactants and / or mild amphoteric surfactants.
Ce gel nettoyant convient particulièrement pour l'hygiène des peaux acnéiques. En effet, outre les effets antifongiques et antiséborrhéiques de l'association piroctone olamine/pyrithione zinc, et l'action antioxydante de la vitamine E, la formulation de ce gel permet de nettoyer la peau sans l'agresser, d'éviter une délipidation excessive et de restaurer une bonne hydratation. This cleaning gel is particularly suitable for the hygiene of acne skin. Indeed, in addition to the antifungal and antiseborrheic effects of the association piroctone olamine / pyrithione zinc, and the antioxidant action of vitamin E, the formulation of this gel makes it possible to clean the skin without attacking it, to avoid excessive delipidation and restore a good hydration.
La présente invention sera mieux comprise à l'aide du complément de description qui va suivre, qui donne en exemple la préparation d'un savon liquide conforme à l'invention. The present invention will be better understood with the aid of the additional description which follows, which gives as an example the preparation of a liquid soap according to the invention.
Il doit être bien entendu, toutefois, que ces exemples sont donnés uniquement à titre d'illustration de l'objet de l'invention, dont ils ne constituent en aucune manière une limitation. It should be understood, however, that these examples are given solely by way of illustration of the object of the invention, of which they in no way constitute a limitation.
EXEMPLE 1 : Préparation d'une composition conforme à l'invention, destinée à être utilisée comme savon
TABLEAU 1
TABLE 1
<tb> DENOMINATION <SEP> DENOMINATION <SEP> ION <SEP>
<tb> COMMERCIALE <SEP> CHIMIQUE <SEP> (p/p) <SEP>
<tb> CETIOL <SEP> HE <SEP> PEG-7-GLYCERYL <SEP> COCOATE <SEP> 1
<tb> TEXAPON <SEP> N <SEP> 40 <SEP> ) <SEP> <SEP> 9
<tb> TEXAPON <SEP> ASV <SEP> ) <SEP> LAURYL <SEP> ETHER <SEP> SULFATE <SEP> DE <SEP> Na <SEP> 9,5
<tb> GELIDERM <SEP> 3000 <SEP> S <SEP> DERIVE <SEP> DE <SEP> COLLAGENE <SEP> ET <SEP> 10
<tb> <SEP> D'ACIDE <SEP> GRAS
<tb> COMPERLAN <SEP> KD <SEP> DIETHANOLAMIDE <SEP> DE <SEP> COPRAH <SEP> 2
<tb> REWOTERIC <SEP> AM2CNM <SEP> COCOAMPHOGLYCINATE <SEP> 5
<tb> <SEP> GLYCERINE <SEP> 7
<tb> VEEGUM <SEP> HS <SEP> 2
<tb> GLYDANT <SEP> DIMETHYL <SEP> HYDANTOINE <SEP> 0,3
<tb> <SEP> CHLORURE <SEP> DE <SEP> Na <SEP> 1
<tb> <SEP> ACIDE <SEP> CITRIQUEa <SEP> 0,33
<tb> <SEP> VITAMINE <SEP> E <SEP> (MICRO-EMULSION) <SEP> 2
<tb> ZINCOMADINE <SEP> A <SEP> 48 <SEP> % <SEP> PYRITHIONE <SEP> ZINC <SEP> 0,5
<tb> <SEP> PIROCTONE <SEP> OLAMINE <SEP> 0,3
<tb> <SEP> PARFUM <SEP> 0,02
<tb> <SEP> COLORANTb <SEP> 0,15
<tb> <SEP> EAU <SEP> DEMINERALISEE <SEP> QSP <SEP> 100
<tb> a: solution à 10% b: solution à 0,5%
Le savon est préparé, à partir des composants indiqués au tableau I ci-dessus, selon la procédure suivante
- on porte l'eau à ébullition dans une première cuve, et l'on maintient l'ébullition pendant 15 minutes ; après refroidissement à 60"C, on procède à la dissolution du chlorure de sodium et du glydant ;
- on introduit successivement, dans une deuxième cuve en inox, et sous agitation planétaire, les composants suivants :Geliderm 3000 S, Texapon ASV,
Texapon N40, Glycérine, Veegum HS, Comperlan KD, Vitamine
E, Cétiol HE, Rewoteric AM2CNM ;
- on mélange le contenu des deux cuves, sous agitation modérée, et on refroidit à une température de 25C ; on ajoute, sous agitation planétaire, la pyrithione zinc, et la piroctone olamine, on ajoute également, si on le souhaite, le parfum ;
- après complète dissolution, on ajuste le pH à 6 par addition de la solution d'acide citrique ;
- Si on le désire, on ajoute le colorant.<tb> DENOMINATION <SEP> NAME <SEP> ION <SEP>
<tb> COMMERCIAL <SEP> CHEMICAL <SEP> (w / w) <SEP>
<tb> CETIOL <SEP> HE <SEP> PEG-7-GLYCERYL <SEP> COCOATE <SEP> 1
<tb> TEXAPON <SEP> N <SEP> 40 <SEP>) <SEP><SEP> 9
<tb> TEXAPON <SEP> ASV <SEP>) <SEP> LAURYL <SEP> ETHER <SEP> SULFATE <SEP> FROM <SEP> Na <SEP> 9.5
<tb> GELIDERM <SEP> 3000 <SEP> S <SEP> DERIVE <SEP> FROM <SEP> COLLAGEN <SEP> AND <SEP> 10
<tb><SEP> OF ACID <SEP> FAT
<tb> COMPERLAN <SEP> KD <SEP> DIETHANOLAMIDE <SEP> FROM <SEP> COPRAH <SEP> 2
<tb> REWOTERIC <SEP> AM2CNM <SEP> COCOAMPHOGLYCINATE <SEP> 5
<tb><SEP> GLYCERINE <SEP> 7
<tb> VEEGUM <SEP> HS <SEP> 2
<tb> GLYDANT <SEP> DIMETHYL <SEP> HYDANTOIN <SEP> 0.3
<tb><SEP> CHLORIDE <SEP> FROM <SEP> Na <SEP> 1
<tb><SEP> ACID <SEP> CITRICO <SEP> 0.33
<tb><SEP> VITAMIN <SEP> E <SEP> (MICRO-EMULSION) <SEP> 2
<tb> ZINCOMADINE <SEP> A <SEP> 48 <SEP>% <SEP> PYRITHIONE <SEP> ZINC <SEP> 0.5
<tb><SEP> PIROCTONE <SEP> OLAMINE <SEP> 0.3
<tb><SEP> PERFUME <SEP> 0.02
<tb><SEP> COLORANTb <SEP> 0.15
<tb><SEP> WATER <SEP> DEMINERALIZED <SEP> QSP <SEP> 100
<tb> a: 10% solution b: 0.5% solution
The soap is prepared from the components indicated in Table I above, according to the following procedure
the water is boiled in a first tank and the boiling is maintained for 15 minutes; after cooling to 60 ° C, the sodium chloride and the glydant are dissolved;
the following components are successively introduced into a second stainless steel tank and under planetary agitation: Geliderm 3000 S, Texapon ASV,
Texapon N40, Glycerin, Veegum HS, Comperlan KD, Vitamin
E, Cetiol HE, Rewoteric AM2CNM;
- The contents of the two tanks are mixed, with moderate stirring, and cooled to a temperature of 25C; zinc pyrithione and piroctone olamine are added with planetary stirring, the perfume is also added if desired;
after complete dissolution, the pH is adjusted to 6 by addition of the citric acid solution;
If desired, the dye is added.
Ainsi que cela ressort de ce qui précède, l'invention ne se limite nullement à ceux de ses modes de mise en oeuvre, de réalisation et d'application qui viennent d'être décrits de façon plus explicite ; elle en embrasse au contraire toutes les variantes qui peuvent venir à l'esprit du technicien en la matière, sans s'écarter du cadre, ni de la portée, de la présente invention. As is apparent from the above, the invention is not limited to those of its modes of implementation, implementation and application which have just been described more explicitly; it encompasses all the variants that may come to the mind of the technician in the field, without departing from the scope or scope of the present invention.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9116406A FR2685638A1 (en) | 1991-12-31 | 1991-12-31 | Compositions for cosmetic and/or dermatological use, comprising a combination of pyrithione zinc, piroctone olamine and a derivative of collagen and of fatty acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9116406A FR2685638A1 (en) | 1991-12-31 | 1991-12-31 | Compositions for cosmetic and/or dermatological use, comprising a combination of pyrithione zinc, piroctone olamine and a derivative of collagen and of fatty acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2685638A1 true FR2685638A1 (en) | 1993-07-02 |
| FR2685638B1 FR2685638B1 (en) | 1995-04-21 |
Family
ID=9420726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR9116406A Granted FR2685638A1 (en) | 1991-12-31 | 1991-12-31 | Compositions for cosmetic and/or dermatological use, comprising a combination of pyrithione zinc, piroctone olamine and a derivative of collagen and of fatty acid |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2685638A1 (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19537509A1 (en) * | 1995-09-27 | 1997-04-10 | Egsto Pharm Pharmazeutische Pr | Prods. for treating irritated skin |
| WO1998013043A1 (en) * | 1996-09-27 | 1998-04-02 | Hoechst Aktiengesellschaft | Use of 1-hydroxy-2-pyridones for the treatment of skin diseases |
| EP1130012A2 (en) * | 2000-02-29 | 2001-09-05 | VaMa FarmaCosmetica S.r.l. | A process for the preparation of amphoglycinates from vegetable oils and butters and the use thereof |
| US7018656B2 (en) | 1996-09-27 | 2006-03-28 | Aventis Pharma Deutschland Gmbh | Antimycotic gel with high active substance release |
| WO2006053708A1 (en) * | 2004-11-22 | 2006-05-26 | Unilever Plc | Improved detergent composition |
| EP1406576B2 (en) † | 2001-07-18 | 2011-06-29 | Unilever PLC | Hair and/or scalp treatment compositions |
| US7981909B2 (en) | 1996-09-27 | 2011-07-19 | Medicis Pharmaceutical Corporation | Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis |
| DE102010013275A1 (en) * | 2010-03-29 | 2011-09-29 | Beiersdorf Ag | Microbiologically stable, application-friendly W / O preparations |
| WO2013025769A3 (en) * | 2011-08-15 | 2014-04-10 | The Procter & Gamble Company | Methods of enhancing skin hydration and improving non-diseased skin |
| US20150374600A1 (en) * | 2009-02-11 | 2015-12-31 | Joseph F. Walsh | Methods and preparations that treat human hair loss |
| WO2016179446A1 (en) * | 2015-05-06 | 2016-11-10 | The Procter & Gamble Company | Methods of cosmetically treating skin conditions with a cosmetic personal cleansing composition |
| US10201481B2 (en) | 2014-03-07 | 2019-02-12 | The Procter & Gamble Company | Personal care compositions and methods of making same |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018049557A1 (en) * | 2016-09-13 | 2018-03-22 | The Procter & Gamble Company | Methods of altering the microbiota composition of skin |
| EP4127645A1 (en) | 2020-03-24 | 2023-02-08 | The Procter & Gamble Company | Methods for testing skin samples |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2123148A1 (en) * | 1971-01-25 | 1972-09-08 | Contier Marcel | Anti seborrhoeic compsns - contg cadmium sulphide and zinc pyridine thione |
| EP0217635A2 (en) * | 1985-09-27 | 1987-04-08 | The Procter & Gamble Company | Hair treatment |
| FR2618072A1 (en) * | 1987-07-17 | 1989-01-20 | Oreal | PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON PYRIDONES AND ANTIBACTERIAL AGENTS |
-
1991
- 1991-12-31 FR FR9116406A patent/FR2685638A1/en active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2123148A1 (en) * | 1971-01-25 | 1972-09-08 | Contier Marcel | Anti seborrhoeic compsns - contg cadmium sulphide and zinc pyridine thione |
| EP0217635A2 (en) * | 1985-09-27 | 1987-04-08 | The Procter & Gamble Company | Hair treatment |
| FR2618072A1 (en) * | 1987-07-17 | 1989-01-20 | Oreal | PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON PYRIDONES AND ANTIBACTERIAL AGENTS |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19537509A1 (en) * | 1995-09-27 | 1997-04-10 | Egsto Pharm Pharmazeutische Pr | Prods. for treating irritated skin |
| WO1998013043A1 (en) * | 1996-09-27 | 1998-04-02 | Hoechst Aktiengesellschaft | Use of 1-hydroxy-2-pyridones for the treatment of skin diseases |
| US6469033B1 (en) | 1996-09-27 | 2002-10-22 | Aventis Pharma Deutschland Gmbh | Use of 1-hydroxy-2-pyridones for the treatment of skin diseases |
| US7018656B2 (en) | 1996-09-27 | 2006-03-28 | Aventis Pharma Deutschland Gmbh | Antimycotic gel with high active substance release |
| US7026337B2 (en) | 1996-09-27 | 2006-04-11 | Aventis Pharma Deutschland Gmbh | Antimycotic gel having high active compound release |
| US7981909B2 (en) | 1996-09-27 | 2011-07-19 | Medicis Pharmaceutical Corporation | Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis |
| EP1130012A2 (en) * | 2000-02-29 | 2001-09-05 | VaMa FarmaCosmetica S.r.l. | A process for the preparation of amphoglycinates from vegetable oils and butters and the use thereof |
| EP1130012A3 (en) * | 2000-02-29 | 2003-10-15 | VaMa FarmaCosmetica S.r.l. | A process for the preparation of amphoglycinates from vegetable oils and butters and the use thereof |
| EP1406576B2 (en) † | 2001-07-18 | 2011-06-29 | Unilever PLC | Hair and/or scalp treatment compositions |
| WO2006053708A1 (en) * | 2004-11-22 | 2006-05-26 | Unilever Plc | Improved detergent composition |
| US20150374600A1 (en) * | 2009-02-11 | 2015-12-31 | Joseph F. Walsh | Methods and preparations that treat human hair loss |
| DE102010013275A1 (en) * | 2010-03-29 | 2011-09-29 | Beiersdorf Ag | Microbiologically stable, application-friendly W / O preparations |
| WO2013025769A3 (en) * | 2011-08-15 | 2014-04-10 | The Procter & Gamble Company | Methods of enhancing skin hydration and improving non-diseased skin |
| CN103889394A (en) * | 2011-08-15 | 2014-06-25 | 宝洁公司 | Methods of enhancing skin hydration and improving non-diseased skin |
| EP2744477B1 (en) | 2011-08-15 | 2018-09-19 | The Procter and Gamble Company | Methods of enhancing skin hydration and improving non-diseased skin |
| US10201481B2 (en) | 2014-03-07 | 2019-02-12 | The Procter & Gamble Company | Personal care compositions and methods of making same |
| WO2016179446A1 (en) * | 2015-05-06 | 2016-11-10 | The Procter & Gamble Company | Methods of cosmetically treating skin conditions with a cosmetic personal cleansing composition |
| CN107530261A (en) * | 2015-05-06 | 2018-01-02 | 宝洁公司 | Utilize the method for cosmetics personal cleaning compositions beauty therapeutic skin disorder |
| US9901584B2 (en) | 2015-05-06 | 2018-02-27 | The Procter & Gamble Company | Methods of cosmetically treating skin conditions with a cosmetic personal cleansing composition |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2685638B1 (en) | 1995-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9499419B2 (en) | Methods and compositions for treatment of skin | |
| FR2536277A1 (en) | NOVEL ANTI-ACNE COMPOSITION BASED ON BENZOYL PEROXIDE AND AT LEAST ONE OTHER ACTIVE INGREDIENT | |
| JP4176912B2 (en) | Cosmetic composition containing moisturizing plant extract | |
| FR2685638A1 (en) | Compositions for cosmetic and/or dermatological use, comprising a combination of pyrithione zinc, piroctone olamine and a derivative of collagen and of fatty acid | |
| KR20060049895A (en) | Compositions containing anti-acne agents and the use thereof | |
| FR2746316A1 (en) | NEW COSMETOLOGICAL OR DERMATOLOGICAL COMPOSITIONS | |
| FR2717079A1 (en) | Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetic and / or dermatological field and methods using it. | |
| EP0904054B1 (en) | USE OF alpha-ALKYLGLUCOSIDES AND alpha-ALKYLGLUCOSIDE ESTERS AS ANTI-MICROBIAL EMULSIFYING AGENTS | |
| JP2022180455A (en) | Antibacterial composition containing essential oil and antibacterial lipid | |
| JP4560156B2 (en) | Cosmetic composition containing moisturizing plant extract | |
| JP2006516022A (en) | Scalp treatment | |
| EP0771557B1 (en) | Use of ascorbic acid as the active agent for the treatment of seborrhea in a cosmetic and/or dermatalogical composition | |
| FR2585244A1 (en) | USE OF LUPINE SOFT SEED POWDER IN CARRYING OUT COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS AND COMPOSITIONS OBTAINED | |
| KR19990077322A (en) | Compositions Containing Antifungal Agents and Sulfur Compounds | |
| KR20220155304A (en) | Personal Care Compositions, Methods of Using Such Compositions and Improving Their Deposition Effects | |
| JP4179971B2 (en) | Moisturizing plant extract and external preparation, cosmetic, bath preparation and detergent containing the extract | |
| US10420962B2 (en) | Organic hair formulation and treatment | |
| JP4551053B2 (en) | Moisturizing plant extract and moisturizing external preparation, cosmetic, bath preparation and detergent composition containing the extract | |
| HU196553B (en) | Cosmetic composition for skin-regeneration containing extract of green beans | |
| JP2009256223A (en) | Extract liquid from egg of sturgeon | |
| FR2646603A1 (en) | CLEANING COMPOSITION | |
| EP0652741B1 (en) | Cosmetic or dermatological compositions, particularly shampoos which may be diluted in water without losing viscosity after dilution | |
| JPH11139951A (en) | Cosmetic | |
| JP2005089402A (en) | External anti-pruritic agent | |
| FR2656523A1 (en) | Compositions for cosmetic and/or dermatological use, comprising metal pidolates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |